Human immunodeficiency virus (HIV) and tuberculosis (TB) coinfection is a serious public health problem. HIV and TB promote each other, accelerating development of HIV to acquired immunodeficiency syndrome (AIDS) and heightening TB mortality. Determining interaction mechanism between HIV and Mycobacterium tuberculosis can lead to development of effective treatments. This study summarizes prevalence status of AIDS and TB coinfection and research advances concerning their interaction mechanism.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1 World Health Organization. Global tuberculosis control: epidemiology strategy financing: WHO report. Geneva: World Health Organization 2009:411.
2 World Health Organization WHO report 2007 global tuberculosis control surveillance planning. Financing. Geneva: WHO Press 2007:270.
3 Tang Shenjie Xiao Heping. “Trend of Tuberculosis and Future Prospect” [J]. Chinese Journal of Practical Internal Medicine 2012 32(8):565-8.
4 McElrath MJ Haynes BF. Induction of immunity to human immunodeficiency virus type-1 by vaccination. Immunity 2010 33(4):542-54.
5 Lawn SD Harries AD Anglaret X et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008 22(15):1897-908.
6 Qin H. Research Progress in Etiopathology of Aids Complicated with Tuberculosis. Journal of Guangxi 2011 27(3):2.
7 Xu Y Pang X. Process in the Research of Double Infection with Aids and Tuberculosis. Tianjin Medical Journal 2007 35(5):393-5.
8 World Health Organization. Global tuberculosis control: WHO Report 2010[EB/OL]. (2010-07-31)[2011-05-31].
9 Xiang X Li X Xu K. Aids Therapeutics. Hefei: Anhui Science and Technology Press 2007: 372
10 Lawn SD Harries AD Meintjes G et al. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2012 26(17):2121-33.
11 Thayil SM Ho YC Bollinger RC et al. Mycobacterium tuberculosis complex enhances susceptibility of CD4 T cells to HIV through a TLR2-mediated pathway. PLoS One 2012 7(7):e41093.
12 Powell R Barengolts D Mayr L et al. The evolution of HIV-1Diversity in Rural Cameroon and its implications in vaccine design and trials. Viruses. 2010 2(2):639-54.
13 Jones KD Hesketh T Yudkin J. Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern. Trans R Soc Trop Med Hyg 2008 102(3):219-24.
14 UNAIDS (2007) TB-HIV: Networking for Policy Change. A Participant’s Guide http://wwwwhoint/tb/hiv/en/.
15 World Health Organization. Global Tuberculosis control: WHO Report 2010(20l0-07-31) [20ll-05-31].
16 Raghavan S Alagarasu K Selvaraj P. Immunogenetics of HIV and HIV associated tuberculosis. Tuberculosis (Edinb) 2012 92(1):18-30.
17 Geldmacher C Zumla A Hoelscher M. Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4T-cell depletion and the development of active tuberculosis. Curr Opin HIV AIDS 20127(3):268-75.
18 Rappuoli R Aderem A. A 2020vision for vaccines against HIV tuberculosis and malaria. Nature 2011 473(7348): 463-9.
19 Sharma SK Mohan A Kadhiravan T. HIV-TB co-infection: epidemiology diagnosis & management. Indian J Med Res 2005 121(4):550-67.
20 Claeye F Jackson T. Project delivery in HIV/AIDS and TB in Southern Africa: the cross-cultural management imperative. J Health Organ Manag 2011 25(4):469-86.
21 Onyebujoh PC Ribeiro I Whalen CC. Treatment Options for HIV-Associated Tuberculosis. J Infect Dis 2007 196(Suppl1):S35-45.
22 Ramana RPV Rajasekaran S Raja A. Natural killer cell-mediated cytokine response among HIV-positive south Indians with pulmonary tuberculosis. J Interferon Cytokine Res 2010 30(1):33-42.
23 Tang Mianying Pan Zhaoxia. Clinical Analysis of 50 Cases of HIV / AIDS Complicated with Tuberculosis. The Journal of the Chinese Antituberculosis Association 2007 29 (5):452-3.
24 Lee S An YS Kim JG et al. A study on the synthesis of polystyrene-silica nanocomposite particles by soap-free emulsion polymerization using cationic initial or in company with colloidal silica sol solution. Nanosci Nanotechnol 2009 9(12):7229-35.